Guillermo Garcia-Manero, Matteo Giovanni Della Porta, Amer Methqal Zeidan, Rami S. Komrokji, Veronika Pozharskaya, Shelonitda Rose, Karen Keeperman, Yinzhi Lai, Sameer Kalsekar, Barkha Aggarwal, Dimana Miteva, David Valcárcel, Pierre Fenaux, Jake Shortt, Uwe Platzbecker, Valeria Santini. "Overall survival (OS) and duration of response for transfusion independence (TI) in erythropoiesis stimulating agent (ESA)–naive patients (pts) with very low-, low-, or intermediate-risk myelodysplastic syndromes (MDS) treated with luspatercept (LUSPA) vs epoetin alfa (EA) in the COMMANDS trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6512